Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.23 USD
Change Today +0.095 / 73.08%
Volume 496.8K
HEWA On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

healthwarehouse.com inc (HEWA) Snapshot

Open
$0.14
Previous Close
$0.13
Day High
$0.31
Day Low
$0.14
52 Week High
01/20/15 - $0.40
52 Week Low
12/16/14 - $0.05
Market Cap
8.5M
Average Volume 10 Days
74.2K
EPS TTM
$-0.07
Shares Outstanding
37.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HEALTHWAREHOUSE.COM INC (HEWA)

Related News

No related news articles were found.

healthwarehouse.com inc (HEWA) Related Businessweek News

No Related Businessweek News Found

healthwarehouse.com inc (HEWA) Details

Healthwarehouse.com, Inc. operates as a virtual retail pharmacy and healthcare e-commerce company that sells generic, brand name, and pet prescription medications; and over-the-counter medications and products in the United States. It also operates as a mail-order pharmacy for sales to 50 states and the District of Columbia. The company sells its products directly to the individual consumers. Healthwarehouse.com, Inc. is headquartered in Florence, Kentucky.

23 Employees
Last Reported Date: 03/30/15

healthwarehouse.com inc (HEWA) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

healthwarehouse.com inc (HEWA) Key Developments

HealthWarehouse.com, Inc. Reports Consolidated Earnings Results for the Year Ended December 31, 2014

HealthWarehouse.com, Inc. reported consolidated earnings results for the year ended December 31, 2014. For the year, net loss narrowed by 67.5%, to $1,783,279 from $5,489,892 a year ago. Net sales were $6,129,660, a 40.1% decrease from the comparable period in 2013, as the company shed non-profitable business relations in 2014 to focus on the higher margin out of pocket cash prescription market. Negative adjusted EBITDA was $596,594, against $870,207 in the year ended December 31, 2013, an improvement of 31.4%.

HealthWarehouse.com Renews Senior Secured Debt with Melrose Capital

HealthWarehouse.com, Inc. announced a renewal of the company's Senior Secured Debt for up to 12 months. Terms of the renewal from Melrose Capital extend the debt six months to September 1, 2015 and conditional on a $350,000 capital raise the maturity date can be extended an additional six months to March 1, 2016.

Healthwarehouse.com and Melrose Capital Advisors, LLC Enter into an Amended and Restated Promissory Note

Healthwarehouse.com is a party to a Loan and Security Agreement, dated as of with Melrose Capital Advisors, LLC. Under the terms of the Loan Agreement, the company borrowed an aggregate of $750,000 from the Lender, including $150,000 and $600,000 during the years ended December 31, 2014 and 2013, respectively. The Loan is evidenced by a promissory note in the face amount of $750,000, as amended. The Senior Note bears interest on the unpaid principal balance until the full amount of principal has been paid at a floating rate equal to the prime rate plus 4.25% per annum (7.50% as of December 31, 2014). Under the terms of the Loan Agreement, the company has agreed to make monthly payments of accrued interest on the first day of every month. The principal amount and all unpaid accrued interest on the Senior Note is payable on March 1, 2015, or earlier in the event of default or a sale or liquidation of the company. The Loan may be prepaid in whole or in part at any time by the company without penalty. The Senior Note contains financial covenants which require the company to meet certain minimum targets for earnings before interest, taxes and non-cash expenses, including depreciation, amortization and stock-based compensation. The company granted the Lender a first priority security interest in all of the company's assets, in order to secure the company's obligation to repay the Loan, including a Deposit Account Control Agreement, dated as of August 18, 2014, which grants the Lender a security interest in certain bank accounts of the company. The Loan Agreement contains customary negative covenants restricting the company's ability to take certain actions without the Lender's consent, including incurring additional indebtedness, transferring or encumbering assets, paying dividends or making certain other payments, and acquiring other businesses. Upon the occurrence of an event of default, the Lender has the right to impose interest at a rate equal to 5.0% per annum above the otherwise applicable interest rate. The repayment of the Loan may be accelerated prior to the maturity date upon certain specified events of default, including failure to pay, bankruptcy, breach of covenant, and breach of representations and warranties. On March 9, 2015, the company and the Lender entered into an Amended and Restated Promissory Note, effective March 1, 2015, pursuant to which the Lender agreed to extend the maturity date of the Senior Note from March 1, 2015 to September 1, 2015. As part of the extension, financial covenants were set which require the company to meet certain minimum targets for EBITDAS for the calendar quarters ending on March 31 and June 30, 2015. In consideration of the Lender extending the maturity date of the Senior Note, the company granted the Lender a five-year warrant to purchase 500,000 shares of common stock of the company at an exercise price of $0.10 per share. The Warrant contains customary anti-dilution provisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HEWA:US $0.23 USD +0.095

HEWA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HEWA.
View Industry Companies
 

Industry Analysis

HEWA

Industry Average

Valuation HEWA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEALTHWAREHOUSE.COM INC, please visit www.healthwarehouse.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.